Deific Life Sciences Private Limited - Due diligence report

A 360° intelligence report on Deific Life Sciences Private Limited: trust score, financial health, credit view, compliance, directors, growt…

2017-03-23 New Delhi, Delhi Active Unlisted Active Compliant
Connect MCP
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Deific Life Sciences Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
62/100
Trust Score
Moderate

Deific Life Sciences Private Limited is assessed as Moderate with a Trust Score of 62/100. Deific Life Sciences Private Limited is an active private limited indian non-government company incorporated in 2017, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.

Report generated on 27 Oct 2026 from the latest processed filings. Deific Life Sciences Private Limited snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
62/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
5/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
55/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 4 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 88/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
SHWETA MEENA 01234567 Director 01/04/2018 6 yrs Approved
RAM SWAROOP MEENA 01234567 Director 01/04/2018 6 yrs Approved
SUMIT KUMAR MEENA 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 40 · Distress 55
Growth signals & trust indicators
Operating for 9 years.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Negative net worth.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence70/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment44/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view33/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 7 events
25 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
28 Dec 2018
Director appointed
RAM SWAROOP MEENA (Additional Director)
11 Aug 2018
Director ceased
AJIT KUMAR MEENA
30 Jul 2018
Director appointed
SHWETA MEENA (Additional Director)
23 Mar 2017
Incorporated
Registered with Roc Delhi
Director appointed
SUMIT KUMAR MEENA (Director)
10

Key Observations

Auto-generated from the data above
Revenue declined 38% over the last 3 financial year(s).
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Celaxis Bioscience Private Limited U24100GJ2020PTC115766 Himatnagar, Gujarat, India
Shree Krishnakanta Pharmaceuticals And Fine Chemicals Private Limited U24232PN2008PTC135131 Ratnagiri, Maharashtra, India
Pdg Pharmachem Private Limited U27310DL2005PTC132747 Na, Delhi, India
Sds Pharmaceuticals Private Limited U24232DL2014PTC264882 New Delhi, Delhi, India
Vansan Pharmaceuticals Private Limited U24232DL2013PTC249819 Delhi, Delhi, India
Servier Pharmaceuticals (India) Private Limited U51397MH1998PTC116694 Mumbai, Maharashtra, India
Curcuma Pharmaceuticals Private Limited U24304BR2019PTC042692 Patna, Bihar, India
Kleon Industries Private Limited U24230MH2021PTC361214 Jalgaon, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Deific Life Sciences Private Limited before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Deific Life Sciences Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score 40/100, margin trends, ownership structure and peer set for Deific Life Sciences Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 62/100, distress signals and MSME payment-delay disclosures - know whether Deific Life Sciences Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Deific Life Sciences Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Deific Life Sciences Private Limited an active company?

Deific Life Sciences Private Limited has MCA status “Active” with a compliance score of 88/100 (Low Risk).

Is Deific Life Sciences Private Limited financially healthy?

Deific Life Sciences Private Limited has a Financial Health Score of 5/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Deific Life Sciences Private Limited?

Its overall Trust Score is 62/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Deific Life Sciences Private Limited?

See the directors and ownership sections above for board and shareholding detail. 3 active director(s) are on record.

Does Deific Life Sciences Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Deific Life Sciences Private Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2025). Overall compliance score: 88/100 (Low Risk).

Is it risky to lend to Deific Life Sciences Private Limited?

Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.